Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Angiogenesis and angiogenesis inhibitors in paediatric diseases.

Literature DB >> 1382987

Angiogenesis and angiogenesis inhibitors in paediatric diseases.

Abstract

Angiogenesis, the generation of new capillaries from existing blood vessels, is rarely observed in the healthy organism, but can present during various paediatric diseases. In this review, we describe recent progress in the understanding of pathological angiogenesis and approaches for an improved therapy of angiogenic childhood diseases.

Mesh：

Substances：

Year: 1992 PMID： 1382987 DOI： 10.1007/bf01957746

Source DB: PubMed Journal: Eur J Pediatr ISSN： 0340-6199 Impact factor: 3.183

49 in total

1. Tumor angiogenesis inhibition by prostaglandin synthetase inhibitors.

Authors: H I Peterson
Journal: Anticancer Res Date: 1986 Mar-Apr Impact factor: 2.480

2. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor.

Authors: F Ishikawa; K Miyazono; U Hellman; H Drexler; C Wernstedt; K Hagiwara; K Usuki; F Takaku; W Risau; C H Heldin
Journal: Nature Date: 1989-04-13 Impact factor: 49.962

3. Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a.

Authors: C W White; H M Sondheimer; E C Crouch; H Wilson; L L Fan
Journal: N Engl J Med Date: 1989-05-04 Impact factor: 91.245

4. Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine.

Authors: T Matsubara; R Saura; K Hirohata; M Ziff
Journal: J Clin Invest Date: 1989-01 Impact factor: 14.808

5. Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth.

Authors: P W Finch; J S Rubin; T Miki; D Ron; S A Aaronson
Journal: Science Date: 1989-08-18 Impact factor: 47.728

6. Medroxyprogesterone acetate, an anti-cancer and anti-angiogenic steroid, inhibits the plasminogen activator in bovine endothelial cells.

Authors: H Ashino-Fuse; Y Takano; T Oikawa; M Shimamura; T Iwaguchi
Journal: Int J Cancer Date: 1989-11-15 Impact factor: 7.396

7. Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1.

Authors: H Tsuda; S Hirohashi; Y Shimosato; T Hirota; S Tsugane; H Yamamoto; N Miyajima; K Toyoshima; T Yamamoto; J Yokota
Journal: Cancer Res Date: 1989-06-01 Impact factor: 12.701

8. Basic fibroblast growth factor is present in cultured human retinoblastoma cells.

Authors: L Schweigerer; G Neufeld; D Gospodarowicz
Journal: Invest Ophthalmol Vis Sci Date: 1987-11 Impact factor: 4.799

9. cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity.

Authors: M Taira; T Yoshida; K Miyagawa; H Sakamoto; M Terada; T Sugimura
Journal: Proc Natl Acad Sci U S A Date: 1987-05 Impact factor: 11.205

10. An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family.

Authors: P Delli Bovi; A M Curatola; F G Kern; A Greco; M Ittmann; C Basilico
Journal: Cell Date: 1987-08-28 Impact factor: 41.582

6 in total

Angiogenesis and angiogenesis inhibitors in paediatric diseases.

1. Tumor angiogenesis inhibition by prostaglandin synthetase inhibitors.

2. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor.

3. Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a.

4. Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine.

5. Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth.

6. Medroxyprogesterone acetate, an anti-cancer and anti-angiogenic steroid, inhibits the plasminogen activator in bovine endothelial cells.

7. Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1.

8. Basic fibroblast growth factor is present in cultured human retinoblastoma cells.

9. cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity.

10. An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family.

1. The role of the vascular phase in solid tumor growth: a historical review.

Review 2. Antiangiogenesis as a novel therapeutic concept in pediatric oncology.

3. Elevated serum vascular endothelial growth factor in children and young adults with Crohn's disease.

4. Genistein, a dietary-derived inhibitor of in vitro angiogenesis.

5. Circulating basic fibroblast growth factor in serum of gastric ulcers patient as a biomarker of wound severity.

6. Adult neck hemangiolymphangioma: a case and review of its etiology, diagnosis and management.